Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death.
Law BYK, Gordillo-Martínez F, Qu YQ, Zhang N, Xu SW, Coghi PS, Mok SWF, Guo J, Zhang W, Leung ELH, Fan XX, Wu AG, Chan WK, Yao XJ, Wang JR, Liu L, Wong VKW.
Law BYK, et al. Among authors: mok swf.
Oncotarget. 2017 May 2;8(18):30077-30091. doi: 10.18632/oncotarget.15616.
Oncotarget. 2017.
PMID: 28404910
Free PMC article.